Neuromodulation for a Novel OCD Biomarker and Treatment

NCT05994053 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Boston University Charles River Campus